Pancreatic Cancer Research

ResearcherWuhan Union HospitalActive in the last 2 years

Yao Guo

Matched on OpenAlex author ID A5100544113. Sources: OpenAlex.

Their work

Papers
8 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 3 papers · 2022: none · 2023: 1 paper · 2024: 2 papers

Papers 8

  1. Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1. Co-author DOI 10.1016/j.intimp.2023.111407↗
  2. Single-cell and spatial transcriptomic analyses reveal the cellular origins and drivers of liver metastasis from pancreatic cancer First author DOI 10.21203/rs.3.rs-4128922/v1↗
  3. USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2. First author DOI 10.1016/j.biopha.2023.115359↗
  4. TRIM47 accelerates aerobic glycolysis and tumor progression through regulating ubiquitination of FBP1 in pancreatic cancer. Co-author DOI 10.1016/j.phrs.2021.105429↗
  5. Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling. First author DOI 10.1186/s10020-021-00300-8↗
  6. Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p/GOT1 axis in pancreatic cancer. Last author DOI 10.1186/s13046-021-01894-x↗
  7. Long noncoding RNA ITGB2-AS1 promotes growth and metastasis through miR-4319/RAF1 axis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jcp.29471↗
  8. Long non-coding RNA MCM3AP-AS1 promotes growth and migration through modulating FOXK1 by sponging miR-138-5p in pancreatic cancer. Co-author DOI 10.1186/s10020-019-0121-2↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Heshui Wu · 4 shared papers, 2020–2021 · strength 0.59
  2. Tao Peng · 3 shared papers, 2021–2024 · strength 0.55
  3. Taoyu Chen · 2 shared papers, 2024 · strength 0.47
  4. Tao Peng · 2 shared papers, 2021–2024 · strength 0.43
  5. Jing Cui · 2 shared papers, 2023–2024 · strength 0.40
  6. Tao Yin · 2 shared papers, 2021–2024 · strength 0.36
  7. Jing Cui · 2 shared papers, 2021 · strength 0.32
  8. Ming Yang · 2 shared papers, 2020–2021 · strength 0.27
  9. Jingyuan Zhao · 1 shared paper, 2024 · strength 0.21
  10. Shanmiao Gou · 1 shared paper, 2023 · strength 0.19
  11. Tao Yin · 1 shared paper, 2023 · strength 0.19
  12. Lei Li · 1 shared paper, 2021 · strength 0.15
  13. Zhengle Zhang · 1 shared paper, 2021 · strength 0.15
  14. Xiaoxiao Zhou · 1 shared paper, 2021 · strength 0.15
  15. Tao Yin · 1 shared paper, 2020 · strength 0.13
  16. Qi Qin · 1 shared paper, 2020 · strength 0.13
  17. Chunyou Wang · 1 shared paper, 2020 · strength 0.13
  18. Ming Yang · 1 shared paper, 2019 · strength 0.12
  19. Guangming Liu · 1 shared paper, 2019 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.